| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.77B | 39.10B | 34.72B | 36.73B | -2.69B | 64.45B |
| Gross Profit | 15.81B | 13.13B | 13.39B | 11.12B | 11.06B | 12.93B |
| EBITDA | 6.15B | 5.64B | 5.93B | 3.98B | 4.96B | 4.72B |
| Net Income | 4.47B | 4.12B | 4.07B | 2.87B | 3.73B | 3.26B |
Balance Sheet | ||||||
| Total Assets | 863.80B | 862.83B | 802.16B | 713.23B | 701.46B | 630.49B |
| Cash, Cash Equivalents and Short-Term Investments | 25.93B | 28.39B | 24.71B | 19.38B | 18.84B | 17.23B |
| Total Debt | 8.86B | 13.41B | 10.23B | 9.65B | 11.29B | 9.73B |
| Total Liabilities | 830.63B | 829.83B | 771.01B | 683.38B | 669.14B | 600.00B |
| Stockholders Equity | 29.93B | 29.86B | 29.54B | 26.84B | 29.01B | 27.22B |
Cash Flow | ||||||
| Free Cash Flow | 4.98B | 2.71B | 4.75B | 5.20B | 7.05B | 10.37B |
| Operating Cash Flow | 4.98B | 2.71B | 4.75B | 5.20B | 7.05B | 10.37B |
| Investing Cash Flow | -80.00M | -56.00M | -408.00M | -786.00M | -5.49B | -11.21B |
| Financing Cash Flow | -4.83B | -4.32B | -2.29B | -3.55B | -620.00M | -992.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | C$72.75B | 16.25 | 15.17% | 3.62% | 4.22% | 13.75% | |
76 Outperform | C$52.39B | 19.11 | 11.34% | 3.28% | 7.10% | 0.39% | |
75 Outperform | C$47.89B | 13.96 | 16.93% | 1.86% | 3.57% | 51.86% | |
72 Outperform | C$88.41B | 13.77 | 12.65% | 3.49% | 15.84% | 31.26% | |
71 Outperform | C$54.90B | 16.73 | 12.98% | 4.11% | -10.77% | -1.88% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | C$49.47B | 7.15 | 17.32% | 0.84% | 2.46% | 15.03% |